• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Osteocalcin and bone histology in osteoporosis].

作者信息

Stracke H, Schulz A, Weber U, Ullmann J, Schatz H

机构信息

Zentrum für Innere Medizin, Universität Giessen.

出版信息

Klin Wochenschr. 1987 Nov 16;65(22):1095-100. doi: 10.1007/BF01736116.

DOI:10.1007/BF01736116
PMID:3501036
Abstract

The decoupling of bone formation and bone resorption causes an insidious bone loss that is responsible for the negative skeletal balance in the frequent form of low turnover osteoporosis. The reduction of bone formation can hardly be verified by clinical methods. Osteocalcin, a non-collagenous bone protein, has proved to be a useful new indicator of bone formation. To establish its predictable value, plasma levels of osteocalcin were compared to conventional serological data of bone turnover and to histomorphometric parameters of iliac crest trabecular bone. In cases of osteoporosis with normal bone turnover activity (as confirmed by histomorphometry) no differences were observed in any of our laboratory data including osteocalcin. However, there was a significant lower mean serum level of osteocalcin in a group of patients with histomorphometrically proven low turnover osteoporosis in comparison to those with normal bone turnover. Serum levels of osteocalcin below 2.0 ng/ml seem to indicate a low turnover in the individual case of osteoporosis while this is unlikely when serum levels above 6.0 ng/ml are measured (according to our RIA).

摘要

相似文献

1
[Osteocalcin and bone histology in osteoporosis].
Klin Wochenschr. 1987 Nov 16;65(22):1095-100. doi: 10.1007/BF01736116.
2
[Comparative study of serum osteocalcin and of the histomorphometric evaluation of iliac biopsy in postmenopausal osteoporosis].[绝经后骨质疏松症患者血清骨钙素与髂骨活检组织形态计量学评估的比较研究]
Rev Rhum Mal Osteoartic. 1984 Nov;51(10):581-4.
3
Active bone turnover of the cortico-endosteal envelope in postmenopausal osteoporosis.绝经后骨质疏松症中皮质-骨内膜包膜的活跃骨转换
J Clin Endocrinol Metab. 1987 May;64(5):954-9. doi: 10.1210/jcem-64-5-954.
4
Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.血清骨钙素:绝经后骨质疏松症骨形成的特异性标志物。
Lancet. 1984 May 19;1(8386):1091-3. doi: 10.1016/s0140-6736(84)92506-6.
5
Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.肝性骨营养不良。80例慢性肝病患者的静态和动态骨组织形态计量学及血清骨钙素水平
Gastroenterology. 1989 Jan;96(1):213-21.
6
Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.在椎体骨质疏松症患者中,吡啶啉交联物的尿排泄量与通过髂嵴活检测得的骨转换相关。
J Bone Miner Res. 1991 Jun;6(6):639-44. doi: 10.1002/jbmr.5650060615.
7
[Osteocalcin (or bone gla-protein), a new biological marker for studying bone pathology].
Presse Med. 1986 Apr 5;15(14):643-6.
8
[Bone metabolism as assessed with selected markers of bone turnover as well as densitometry analysis in patients after successful kidney transplantation].[通过选定的骨转换标志物以及成功肾移植患者的骨密度分析评估骨代谢]
Przegl Lek. 2001;58(11):979-84.
9
Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.通过测量血清骨钙素评估绝经后骨质疏松症患者的骨转换情况。
J Lab Clin Med. 1983 Oct;102(4):470-6.
10
Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry.
J Clin Endocrinol Metab. 1986 Oct;63(4):892-7. doi: 10.1210/jcem-63-4-892.

引用本文的文献

1
Diversity, Mechanism, and Optogenetic Application of Light-Driven Ion Pump Rhodopsins.光驱动离子泵视紫红质的多样性、机制及光遗传学应用。
Adv Exp Med Biol. 2021;1293:89-126. doi: 10.1007/978-981-15-8763-4_6.
2
Structure-Function Relationship of Channelrhodopsins.通道视紫红质的结构-功能关系。
Adv Exp Med Biol. 2021;1293:35-53. doi: 10.1007/978-981-15-8763-4_3.
3
BGP (osteocalcin, bone-Gla-protein) in involutional osteoporosis.
Clin Rheumatol. 1989 Jun;8 Suppl 2:30-4. doi: 10.1007/BF02207230.

本文引用的文献

1
The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis.骨形成与骨吸收的耦合:对该概念及其与骨质疏松症发病机制相关性的批判性分析。
Metab Bone Dis Relat Res. 1982;4(1):1-6. doi: 10.1016/0221-8747(82)90002-9.
2
New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.骨代谢的新型生化标志物。通过放射免疫分析法测定正常受试者和骨病患者血浆中的骨γ-羧基谷氨酸蛋白。
J Clin Invest. 1980 Nov;66(5):878-83. doi: 10.1172/JCI109954.
3
Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting.
在医院环境中通过血清骨钙素测量评估骨转换的临床研究
J Clin Endocrinol Metab. 1984 Aug;59(2):228-30. doi: 10.1210/jcem-59-2-228.
4
Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease.尿γ-羧基谷氨酸和血清骨钙素作为骨标志物:骨质疏松症和佩吉特病的研究
J Clin Endocrinol Metab. 1983 Dec;57(6):1221-5. doi: 10.1210/jcem-57-6-1221.
5
Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.通过测量血清骨钙素评估绝经后骨质疏松症患者的骨转换情况。
J Lab Clin Med. 1983 Oct;102(4):470-6.
6
Serum osteocalcin in the treatment of inherited rickets with 1,25-dihydroxyvitamin D3.
J Clin Endocrinol Metab. 1983 May;56(5):1063-7. doi: 10.1210/jcem-56-5-1063.
7
Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.绝经后女性雌激素和钙预防期间血清骨钙素的变化
Calcif Tissue Int. 1984 Sep;36(5):536-40. doi: 10.1007/BF02405361.
8
Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis.血清骨钙素:绝经后骨质疏松症骨形成的特异性标志物。
Lancet. 1984 May 19;1(8386):1091-3. doi: 10.1016/s0140-6736(84)92506-6.
9
[Technical improvement and application of histo-biopsy in bone marrow and bones].[骨髓与骨骼组织活检的技术改进及应用]
Klin Wochenschr. 1966 Mar 15;44(6):326-34. doi: 10.1007/BF01752281.
10
Changes in mineral content and biochemical bone markers at the menopause.
Isr J Med Sci. 1985 Nov;21(11):875-7.